Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
- - - - - - - 0
0.58%0.66%17.76x2.02x3.85x10.09x11.52x 68.85B
0.61%0.63%25.64x3.88x5.3x15.59x19.32x 52.13B
-.--%-.--%34.55x6.94x11.7x22.35x26.04x 43.46B
3.31%3.4%-46.16x2.53x3.26x9.62x11.22x 41.24B
-.--%-.--%24.47x1.63x3.57x11.94x13.55x 30.41B
-.--%-.--%-7.13x4.33x10.08x-6.19x-5.82x 24.53B
-.--%-.--%77.55x - - - - 23.42B
-.--%0.05%64.32x5.78x6.31x43.41x48.98x 19.75B
-.--%-.--%24.47x3.59x5.19x13.62x18.87x 16.57B
-.--%-.--%-36.62x-6.49x17.52x-47.76x-54.5x 15.95B
-.--%-.--%-111.49x12182.2x11.98x-85.75x-119.56x 11.84B
-.--%-.--%17.66x - 3.62x14.01x16.36x 11.52B
-.--%-.--%46.82x - - - - 10.46B
0.18%0.19%50.59x20.63x30.53x43.18x44.53x 9.96B
2.86%3.24%11.97x1.08x1.81x7.29x9.85x 6.28B
0.37%0.44%27.66x - 7.41x19.67x23.5x 5.64B
-.--%-.--%-108.47x - - - - 5.33B
Average 0.47% 0.51% 6.68x 1,019.01x 8.72x 5.08x 4.56x 22.07B
Weighted average by Cap. 0.58% 0.61% 13.00x 426.35x 7.18x 8.77x 9.74x
Biopharmaceuticals